Bayer is signaling it has had enough of litigation, leaving the future of a crop protection tool in limbo.
Executives tell the Wall Street Journal they are nearing the end of the road for glyphosate, the main ingredient in RoundUp. CEO Bill Anderson says they are barely breaking even, and litigation costs often put them in the red.
More than 65,000 cases are pending against Bayer right now, and the company has around $16 billion set aside for settlements.
Anderson stands by glyphosate, saying it has been proven safe to use, even by the FDA. Bayer produces roughly 40 percent of the supply used by U.S. farmers.
Related Stories
Sen. Amy Klobuchar has four years remaining in her Senate term and could decide to continue serving in that role while campaigning for Governor of Minnesota.
Beef x Dairy cattle with strong genetics and documentation are earning prices comparable to native feeders.
Reliable waterways lower costs, protect export demand, and support long-term farm profitability.
STRAUSS CEO Henning Strauss joined us with a preview of “Meet Strauss: The Tool You Wear,” premiering live tonight at 7:30 ET — only on RFD Network and RFD+
Mike Steenhoek of the Soy Transportation Coalition shares how extreme winter weather is affecting the ag transportation network and what producers should keep in mind as conditions slowly improve.
Strong White House backing supports ethanol demand, but timing now hinges on Congress resolving procedural — at the same time as they push toward a spending bill to avert another federal government shutdown.
